Home Privacy Archive Realtime Report

Stock Trading History of Scott Robert A

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Scott Robert A since year 2005. The trader's CIK number is 1248520. At the time of this reporting, Scott Robert A is the Sr VP Clinical Dev & of Atherogenics Inc (stock ticker symbol AGIX).

Stock purchases, sales, and option exercises reported by *Scott Robert A* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2007-04-02	AGIX	Atherogenics Inc	Purchase	36,000	2.77	99,576
2005-12-28	AGIX	Atherogenics Inc	Sale	20,000	20.01	400,140
2005-12-28	AGIX	Atherogenics Inc	Option Exercise	16,100	7.04	113,344

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Scott Robert A (Sr VP Clinical Dev & of Atherogenics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.